Akèy › Kansè nan tete › Virginia › Charlottesville
Etid klinik pou Kansè nan tete nan Charlottesville, VA
9 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Charlottesville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Ap rekriteFaz 3
- Research Site, Charlottesville
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Ap rekriteFaz 2
- University of Virginia Health System, Charlottesville
The Vanguard Study: Testing a New Way to Screen for Cancer
Ap rekriteVolontè an sante akeyi
- Sentara Martha Jefferson Hospital, Charlottesville
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Ap rekriteFaz 3
- University of Virginia Cancer Center, Charlottesville
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
Ap rekriteVolontè an sante akeyi
- University of Virginia, Charlottesville
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
Ap rekriteFaz 3
- University of Virginia, Charlottesville
HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)
Ap rekriteFaz 1/2
- University of Virginia, Charlottesville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Charlottesville
Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer
Ap rekriteFaz 2/3
- University of Virginia, Charlottesville
Etid Kansè nan tete nan lòt vil
- New York City, NY134 etid
- Houston, TX126 etid
- Boston, MA111 etid
- Nashville, TN80 etid
- Los Angeles, CA72 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Durham, NC63 etid
- Queens, NY63 etid
- Chicago, IL58 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan Charlottesville
- Kansè Poumon ki pa ti selil21 etid
- Leksemi mieloïd egi16 etid
- Kansè pwostat15 etid
- Kansè Metastatik13 etid
- Kansè Endomèt13 etid
- Kansè (tout kalite)13 etid
- Kansè poumon13 etid
- Ensifizyans kadyak11 etid
- Kansè ovè10 etid
- Kansè kolorektal10 etid
- Dyabèt tip 19 etid
- Kansè pankreyas9 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.